Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAMPITI TRIAL: Tranexamic Acid in Traumatic Injury
NCT02535949Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Feb 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tranexamic acid in traumatic injury, hemorrhage, Shock, sponsored by Washington University School of Medicine. Started Feb 2016; status: completed.
02
Drugs
tranexamic acid
03
Conditions
traumatic injuryhemorrhageShock
Beyond the preview
Go deeper on NCT02535949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02535949.